Vaxxinity

Vaxxinity EBITDA per Share

The EBITDA per Share of Vaxxinity (VAXX) as of Oct 18, 2026 is -0.46 USD. In the previous year, EBITDA per Share was -0.60 USD — a change of -23.63% (higher).

EBITDA per Share

-0.46USD

YoY

-23.63%

Last updated:

EBITDA per Share of Vaxxinity is 2023 -0.46 USD. EBITDA per Share of Vaxxinity was 2022 -0.60 USD. It decreases by -23.63% higher compared to the previous year.

The Vaxxinity EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
-0.11 USD
Jan 1, 2020
-0.26 USD
Jan 1, 2021
-1.00 USD
Jan 1, 2022
-0.60 USD
Jan 1, 2023
-0.46 USD
The Vaxxinity EBITDA per Share history
YEAREBITDA per ShareYoY
-0.46USD-23.63%
-0.60USD-39.52%
-1.00USD+285.51%
-0.26USD+136.31%
-0.11USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vaxxinity Stock analysis

What does Vaxxinity do? Vaxxinity Inc., headquartered in Dallas, Texas, is a biotechnology company operating in the Health Care sector. The company focuses on developing prophylactic and therapeutic vaccines for chronic diseases and infectious conditions with significant unmet medical needs. Its Vaxxine Platform enables the creation of synthetic peptide vaccines targeting Alzheimer's, Parkinson's, migraines, and hypercholesterolemia. Vaxxinity has a pipeline of six programs, including UB-311 for Alzheimer's and UB-312 for Parkinson's, among others. Listed on November 11, 2021, the company employs 87 full-time staff. Vaxxinity is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vaxxinity stock

EBITDA per Share of Vaxxinity is -0.46 USD in 2023.

EBITDA per Share of Vaxxinity changed from -0.60 USD to -0.46 USD, representing a -23.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Vaxxinity since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Vaxxinity

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Vaxxinity